NO20060733L - Pyrazoliner som PAR-1 antagonister for behandling av kardiovaskulaere sykdommer - Google Patents
Pyrazoliner som PAR-1 antagonister for behandling av kardiovaskulaere sykdommerInfo
- Publication number
- NO20060733L NO20060733L NO20060733A NO20060733A NO20060733L NO 20060733 L NO20060733 L NO 20060733L NO 20060733 A NO20060733 A NO 20060733A NO 20060733 A NO20060733 A NO 20060733A NO 20060733 L NO20060733 L NO 20060733L
- Authority
- NO
- Norway
- Prior art keywords
- pyrazolines
- treatment
- par
- antagonists
- cardiovascular diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10331951 | 2003-07-15 | ||
| DE102004010545A DE102004010545A1 (de) | 2003-07-15 | 2004-03-04 | Pyrazoline |
| PCT/EP2004/007227 WO2005007157A1 (de) | 2003-07-15 | 2004-07-02 | Pyrazoline als par-1-antagonisten zur behandlung von herz-kreislauf-erkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20060733L true NO20060733L (no) | 2006-04-10 |
Family
ID=34081645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20060733A NO20060733L (no) | 2003-07-15 | 2006-02-15 | Pyrazoliner som PAR-1 antagonister for behandling av kardiovaskulaere sykdommer |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1648447A1 (pt) |
| AU (1) | AU2004257406A1 (pt) |
| BR (1) | BRPI0412554A (pt) |
| CA (1) | CA2532316A1 (pt) |
| MA (1) | MA27905A1 (pt) |
| MX (1) | MXPA06000507A (pt) |
| NO (1) | NO20060733L (pt) |
| WO (1) | WO2005007157A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004061751A1 (de) * | 2004-12-22 | 2006-07-06 | Bayer Healthcare Ag | Cyanoguanidin-substituierte Pyrazoline |
| DE102004061748A1 (de) * | 2004-12-22 | 2006-07-06 | Bayer Healthcare Ag | Azetidin-substituierte Pyrazoline |
| DE102004061747A1 (de) * | 2004-12-22 | 2006-07-06 | Bayer Healthcare Ag | Thiophen-substituierte Pyrazoline |
| ES2722431T3 (es) * | 2014-12-08 | 2019-08-12 | Bayer Pharma AG | Novedosos compuestos de aril-cianoguanidina |
| WO2016166186A1 (en) | 2015-04-17 | 2016-10-20 | Bayer Pharma Aktiengesellschaft | Novel aryl-cyanoguanidine compounds |
| EP3283478A1 (en) * | 2015-04-17 | 2018-02-21 | Bayer Pharma Aktiengesellschaft | Novel aryl-cyanoguanidine compounds |
| EP3109237A1 (en) | 2015-06-22 | 2016-12-28 | AnaMar AB | Novel 5-ht2 antagonists |
| CN111892585A (zh) * | 2020-08-05 | 2020-11-06 | 杭州维坦医药科技有限公司 | 作为p2x3受体拮抗剂的n-甲酰胺基吡唑啉类衍生物及应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69131899T2 (de) * | 1990-07-13 | 2000-08-17 | Rohm And Haas Co., Philadelphia | N-Aryl-3-aryl-4-substituierte-4,5-dihydro-1H-pyrazol-1-carboxamide und Verfahren zu deren Herstellung |
| DE4217862A1 (de) * | 1991-08-28 | 1993-03-04 | Bayer Ag | Substituierte pyrazoline |
| DE4217863A1 (de) * | 1991-08-28 | 1993-03-04 | Bayer Ag | Substituierte pyrazoline |
| DE4217864A1 (de) * | 1992-05-29 | 1993-12-02 | Bayer Ag | Substituierte Pyrazoline |
| DE4233713A1 (de) * | 1992-10-07 | 1994-04-14 | Bayer Ag | Substituierte 4,5-Dihydro-1-pyrazolcarbonsäureanilide |
-
2004
- 2004-07-02 MX MXPA06000507A patent/MXPA06000507A/es unknown
- 2004-07-02 CA CA002532316A patent/CA2532316A1/en not_active Abandoned
- 2004-07-02 WO PCT/EP2004/007227 patent/WO2005007157A1/de not_active Ceased
- 2004-07-02 BR BRPI0412554-1A patent/BRPI0412554A/pt not_active Application Discontinuation
- 2004-07-02 AU AU2004257406A patent/AU2004257406A1/en not_active Abandoned
- 2004-07-02 EP EP04740582A patent/EP1648447A1/de not_active Withdrawn
-
2006
- 2006-01-06 MA MA28710A patent/MA27905A1/fr unknown
- 2006-02-15 NO NO20060733A patent/NO20060733L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0412554A (pt) | 2006-09-19 |
| WO2005007157A1 (de) | 2005-01-27 |
| MXPA06000507A (es) | 2006-04-05 |
| CA2532316A1 (en) | 2005-01-27 |
| AU2004257406A1 (en) | 2005-01-27 |
| EP1648447A1 (de) | 2006-04-26 |
| MA27905A1 (fr) | 2006-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20074592L (no) | Acetylenyl-pyrazolo-pyrimidinderivater som mGluR2-antagonister | |
| NO20055421L (no) | Kinolinderivater som fosfodiestrase-inhibitorer | |
| NO20060324L (no) | [1,8]Naftyridin-2-oner og relaterte forbindelser for behandling av Schizofreni | |
| MX2007000505A (es) | Derivados de oxindol sustituidos y medicamentos que contienen los mismos. | |
| NO20051962L (no) | Fenetanolaminderivater for behandling av respiratoriske sykdommer | |
| NO20050828L (no) | lndol-3-svovelderivater | |
| NO20055649L (no) | Substituert dihydrokinazolin med antiviale egenskaper | |
| NO20064201L (no) | Glukopyranosylsubstituerte benzolderivater, medikamenter inneholdende slike forbindelser, deres anvendelse og fremstilling | |
| NO20025601L (no) | Arylmetylaminderivater for anvendelse som tryptaseinhibitorer | |
| NO20054905L (no) | 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika | |
| NO20074258L (no) | Pyridin-2-karboksamidderivater som MGLUR5 antagonister | |
| ATE365720T1 (de) | Agonisten von beta-adrenorezeptoren | |
| NO20041041L (no) | Fenetanolaminderivater for behandling av respiratoriske sykdommer | |
| NO20062335L (no) | Nye diazaspiroalkaner og deres anvendelse i behandlingen av CCR8 medierte sykdommer | |
| NO20054414L (no) | Dihydropteridinoner, metoder for deres fremstilling og bruk av disse som medisiner | |
| NO20092342L (no) | Azaspiroderivativater | |
| TW200504067A (en) | New substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions | |
| NO20066055L (no) | Pyridinderivater | |
| NO20051600L (no) | 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer | |
| NO20052796L (no) | Indolylpyrazinonderivater anvendelige for behandling av hyper-proliferative forstyrrelser og sykdommer assosiert med angiogenese | |
| NO20056010L (no) | Biaryloksymetylaren-karboksylsyrer | |
| MXPA03012013A (es) | Derivados de 1-oxa-2,8-diaza-spiro[4,5]dec-2-eno sustituidos como medicamento para el tratamiento de dolor. | |
| NO20082496L (no) | Pyrazinderivater | |
| NO20056192L (no) | Kapaseinhibitorer og anvendelse derav | |
| NO20061363L (no) | Pyrazolo- og imidazo- pyrimidinderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |